Skip to content

NOVAPLEX

Active Private limited companyfounded 2024active for 2 yearsChemin du Baimont 1, 4400 FlémalleKBO/BCE: BE 1006.281.364 #9 company by equity in Modave, Wholesale and retail trade sector

Lifetime

2 annual accounts with figures on one time axis
peak of €52,898 in 2025
€52,898▲ 289%
peak of €36,666 in 2025
€36,666▲ 301%
peak of €91,802 in 2025
€91,802▲ 66.5%
€27,320▲ 49.5%
Board2 names since 2024
2 directors and 1 other
Documentsfilings and deeds
17-08-202617 days late
2025micro format
Gross margin from €13,605 to €52,898Result from €9,136 to €36,666Registered office moved from Modave to Flémalle 02-10Equity from €55,136 to €91,802Debts from €18,278 to €27,320Cash from €30,091 to €85,554

Key points

from the 2025 annual accounts

Turnover

≈ €260,000 estimated

The micro format states no turnover.

Liquidity

3.22 was 2.19 in 2024

Short-term debts rose from €17,889 to €27,079.

Position in the sector

77.1%

Higher solvency than 85% of companies in retail trade. The sector median is 33.2%, over 25,388 companies.

2025 accounts filed 17 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as NOVAPLEX has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for NOVAPLEX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • founderdeed of 23-02-2024
  • founderdeed of 23-02-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1006281364
Registered office moved from Modave to Flémalle The registered office moved from Rue Biette, 5a à 4577 Modave to Chemin du Baimont 1, 4400 Flémalle · General meeting of 27-02-2025 · Gazette deed
First establishment Rue Biette 5A, Modave
Incorporation Founded by and · 100 shares · (director) and (director) appointed · published on 23-02-2024 · Gazette deed
All 6 events

Comparable companies

same main activity, similar in size and age
Company
NOVAPLEX Modave €119,122 €52,898 77.1% -
API PHARMA Liège €116,460 €52,678 59.7% -
Farma Jana Lo-Reninge €118,424 €57,937 80.1% -
O.Sabur Genk €129,423 €57,943 57.1% -
MONTPHARMA Forest €135,487 €55,087 82.3% -
Quality Pharmaceutical Service La Bruyère €110,124 €59,832 73.5% -
ELIAM Hasselt €122,187 €65,184 84.3% -

These companies have the same main activity as NOVAPLEX: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €110,000 and €135,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 21-02-2024Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Establishment unit
2.357.868.9714577 Modave, since 13-03-2024
Financial year end
31 December
Peppol
Reachable since 12-12-2025
Company details

Annual accounts 2025

€119,122▲ 62.3%
Filing
Filed on 17-08-2026
Financials

Insights on NOVAPLEX

NOVAPLEX has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91,802 and a net result of €36,666.

Its solvency ranks better than 85% of 25,388 sector peers (NACE 47) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NOVAPLEX

What is the company number of NOVAPLEX?
The company number of NOVAPLEX is 1006.281.364. The VAT number is the same number with BE in front: BE 1006.281.364.
Where is NOVAPLEX based?
The registered office is at Rue Biette 5A, 4577 Modave.Company details
What does NOVAPLEX do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of NOVAPLEX?
NOVAPLEX is a private limited company (BV).
When was NOVAPLEX founded?
NOVAPLEX was founded on 21-02-2024.
Is NOVAPLEX still active?
Yes, NOVAPLEX is an active enterprise in the KBO register.
What is the turnover of NOVAPLEX?
The turnover in financial year 2025 is about €260,000. This figure is estimated from the gross margin of €52,898 and 54 comparable companies (NACE 477). It probably lies between €130,000 and €370,000.Financials
Is NOVAPLEX profitable?
In financial year 2025, NOVAPLEX made a profit of €36,666.
Where can I find the annual accounts of NOVAPLEX?
NOVAPLEX filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NOVAPLEX due?
NOVAPLEX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.